GAIN THERAPEUTICS, INC (GANX) Operating cash flow 2020–2025
GAIN THERAPEUTICS, INC (GANX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$18.5MFY2025 · since FY2020: -$3.2M → -$18.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.5M | +2.2% |
| FY2024 | -$18.9M | -0.0% |
| FY2023 | -$18.9M | -28.4% |
| FY2022 | -$14.7M | -18.8% |
| FY2021 | -$12.4M | -281.6% |
| FY2020 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice